Trilogy’s revenue surges 63% on strong Aus sales

Company News

by David Chau

New Zealand company, Trilogy International Ltd (ASX:TIL), has announced its first half results ending 30 September 2016.

The company, which makes natural products and home fragrance brands such as Goodness Natural Beauty Lab and ECOYA, reported that its revenue surged by 63% to $47.8 million.

Other highlights include Trilogy’s EBITDA growing 34% to $7.2 million, and its NPAT up by 10% to $3.5 million.

Trilogy’s sales in Australia outperformed its home market, New Zealand. In fact, sales of its Natural Products range surged by 15%, and contributed $17.8 million to its revenue.

As for its guidance in the 2017 financial year, the company expects revenue to be between $100 million to $110 million – which is a 20% to 32% increase compared to the last financial year.

David Chau

Finance News Network
David joined FNN in April 2016. In addition to presenting the Market Outlook and latest business news stories, David interviews senior economists and CEOs of ASX-listed companies. Prior to working for FNN, David was a litigation lawyer.